about
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?Cannabinoid hyperemesis: a case series of 98 patientsDifferential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.The endocannabinoid system as an emerging target of pharmacotherapyThe cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurinHarm reduction--the cannabis paradoxMarijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalizationInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionCannabinoids reveal separate controls for whisking amplitude and timing in ratsAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemA review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter SurveyImmunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212HIV-1 neuropathogenesis: glial mechanisms revealed through substance abusePreclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.Therapeutic potential of cannabinoid receptor agonists as analgesic agents.New horizons for newborn brain protection: enhancing endogenous neuroprotectionMDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningCannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture.Drugs of abuse and the aging brain.Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.Sigma receptors [σRs]: biology in normal and diseased statesEffects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion modelWIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinaseEndocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease.The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.Novel targets for Spinal Cord Injury related neuropathic pain.Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoids
P2860
Q24564956-897D2543-1736-4106-8197-D8B2CBD2CD19Q24633749-FA806ED3-6942-4C0B-9207-AAF06A370E48Q24643957-7301B0CD-B167-48A4-872D-6FFBF61FD695Q24648473-DB1FBFEA-0999-4E73-9344-E37BEA172514Q24676808-3238FD54-A2A4-4CF8-93C7-ABE67741BEA7Q24814542-FF325D5E-EC37-4EF9-B385-8DB7E4FFD79FQ27009287-D9EEDB01-6950-4107-A030-C25EF5C3636EQ28283718-66C02C78-C886-4604-BF19-89D6FF646971Q28293379-30F8C58E-0576-4FC2-9BD5-E21FB4E385DFQ28389419-165C97B9-0F9A-4A37-921C-D4CC1385B398Q34013540-68D56FB1-D264-4B17-BB9F-EF9093160AB1Q34077887-04A5D583-F69A-4747-9945-C99D43FB6055Q34912871-28A0A3BE-02E7-4D66-9F92-89E8009A2E65Q35009465-76A10231-1115-4E4F-92F9-3C80492C49A6Q35863912-113EBBC8-9E53-4C15-B1F6-1AC882E99DE8Q36187065-AF278BB0-6859-4121-8B14-5C49EEDE23C4Q36374839-45BC7CBA-9984-48C0-B241-B83FC1D6136DQ36410784-817890F8-B381-40FE-B30C-71ECBB1DAE6EQ36416372-C4B5DACF-660F-4097-B725-01D312E56D90Q36681491-5953804F-3F52-497F-9C70-8F813FF5114EQ36779439-26D9D003-E9D4-4104-9D28-ED05BBC8F45EQ36892931-9270633D-3C24-4FD8-8184-1B1148B7CA32Q36961126-05F2FA29-917D-456B-A68A-239D67C64B4AQ37000551-671E724A-3AEB-47CA-ABBA-E2BC9A674359Q37054169-2216E6E6-AFD2-4D05-B1C8-0BC99F739709Q37074777-6AA74FEA-3CC7-48DF-BB97-B3A18BA584C1Q37087780-667D9FD4-A769-48D5-BE38-AB147A173CF4Q37312658-5F77E445-E3D7-47CB-9B90-2D13BE9D3F8EQ37416662-81A14BEC-9F7A-4E16-A040-F247C1C1CACEQ37432329-72D3157A-3561-4810-86AF-BCEC335F6724Q37512670-61F16491-CCF0-471B-8757-ABB7B1D0B298Q37553341-5343ADD9-A26F-4C0A-B306-2EEE8EF6EF32Q37892742-BB826BD9-AB64-4075-AA9E-E00CEDE720C1Q38041231-C6FADC04-0B5B-4281-B697-6956F6518596Q38247946-B2F5BCC0-F22F-418D-AB6C-034234D145A4Q38287745-6E101E44-2531-40FA-BEEE-C3AB6D9DAF8EQ39135597-0285DA53-B24B-4E6C-B691-B8C6B2CA224AQ39181416-0BD44594-1A9E-4428-A92E-334A20D7F9B5Q39411024-32EC89BF-B749-4E58-A54E-1B652614ED58Q39969705-1777306D-5AA9-4595-8816-8BAFEB98062C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Therapeutic potential of cannabinoids in CNS disease.
@ast
Therapeutic potential of cannabinoids in CNS disease.
@en
type
label
Therapeutic potential of cannabinoids in CNS disease.
@ast
Therapeutic potential of cannabinoids in CNS disease.
@en
prefLabel
Therapeutic potential of cannabinoids in CNS disease.
@ast
Therapeutic potential of cannabinoids in CNS disease.
@en
P1433
P1476
Therapeutic potential of cannabinoids in CNS disease.
@en
P2093
J Ludovic Croxford
P304
P356
10.2165/00023210-200317030-00004
P577
2003-01-01T00:00:00Z
P6179
1024546845